Home > Resources > Whitepapers > Corporate Compliance Program Plan

Corporate Compliance Program Plan

Cedars-Sinai Medical Center, dba Cedars-Sinai Health System (“Cedars-Sinai”), a California nonprofit public benefit corporation and its affiliated organizations ("Cedars-Sinai"), are dedicated to patient care of the highest quality, world-class medical research, and state-of-the-art medical and healthcare training. Cedars-Sinai maintains the highest ethical standards and uses its best efforts to comply with both the letter and spirit of all federal, state and local laws, regulations, rules, guidelines and ordinances (“Laws”).

I'm For Real

Enter your details once to access all our information and resources

Spotlight

Coloplast

"Coloplast is among the world’s leading suppliers of intimate healthcare products and services. As a group, we have built our current position by listening to consumers and understanding their needs. For more than 50 years, Coloplast has developed and marketed innovative products that make life easier for people with diseases of a personal and private nature. Our focus is centered on ostomy care, continence care, urology care and skin and wound care. "

OTHER WHITEPAPERS
news image

Inclusive Health Systems: Innovations towards HealthEquity in Africa

whitePaper | January 13, 2023

The COVID-19 pandemic and response measures presented many hardships to people living in Sub-Saharan Africa.

Read More
news image

The State of Healthcare Performance Improvement

whitePaper | November 8, 2019

The report provides healthcare leaders with 4 actionable strategies, supported by successful practices that combine performance improvement tactics, technology and survey of hospital and health system leaders on the state of performance improvement and cost transformation efforts within their organizations.

Read More
news image

Planning your first-in-human trial

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

Read More
news image

THE FUTURE OF HEALTHCARE

whitePaper | April 7, 2022

The global healthcare industry is facing a seemingly insurmountable number of challenges – from aging populations and staff shortages to rising costs

Read More
news image

Information Protection: A People-Centric Approach to Safeguarding Healthcare Data

whitePaper | December 6, 2022

Cybersecurity has become one of the most complex and urgent issues facing the healthcare industry. The number of cyber attacks continues to grow, and attackers are getting even more sophisticated at compromising systems.

Read More
news image

The cultural shift to smart manufacturing in the medical device industry

whitePaper | February 22, 2023

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier.

Read More

Inclusive Health Systems: Innovations towards HealthEquity in Africa

whitePaper | January 13, 2023

The COVID-19 pandemic and response measures presented many hardships to people living in Sub-Saharan Africa.

Read More

The State of Healthcare Performance Improvement

whitePaper | November 8, 2019

The report provides healthcare leaders with 4 actionable strategies, supported by successful practices that combine performance improvement tactics, technology and survey of hospital and health system leaders on the state of performance improvement and cost transformation efforts within their organizations.

Read More

Planning your first-in-human trial

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

Read More

THE FUTURE OF HEALTHCARE

whitePaper | April 7, 2022

The global healthcare industry is facing a seemingly insurmountable number of challenges – from aging populations and staff shortages to rising costs

Read More

Information Protection: A People-Centric Approach to Safeguarding Healthcare Data

whitePaper | December 6, 2022

Cybersecurity has become one of the most complex and urgent issues facing the healthcare industry. The number
of cyber attacks continues to grow, and attackers are getting even more sophisticated at compromising systems.

Read More

The cultural shift to smart manufacturing in the medical device industry

whitePaper | February 22, 2023

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier.

Read More
More Whitepapers

Spotlight

Coloplast

"Coloplast is among the world’s leading suppliers of intimate healthcare products and services. As a group, we have built our current position by listening to consumers and understanding their needs. For more than 50 years, Coloplast has developed and marketed innovative products that make life easier for people with diseases of a personal and private nature. Our focus is centered on ostomy care, continence care, urology care and skin and wound care. "

Events

The 10th International Conference on Public Health

Conference